Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Dec;43(6):376-82.
doi: 10.1007/BF02553282.

Reduced strength of rat cortical bone after glucocorticoid treatment

Affiliations

Reduced strength of rat cortical bone after glucocorticoid treatment

G Ortoft et al. Calcif Tissue Int. 1988 Dec.

Abstract

The aim of the present study was to examine the effect of therapeutic doses of glucocorticoids on the mechanical strength of rat femora. Groups of rats were treated with a glucocorticoid--methylprednisolone (Solu-Medrol)--1 mg/kg/day for 5, 10, 30, and 90 days. One group served as intact control, two control groups were injected with saline for 30 and 90 days and another group of rats had restricted access to food so that their weight gain was reduced to the same extent as the group treated with glucocorticoid for 90 days. The strength of the femora was analyzed by means of a materials testing machine. No differences were found in the short-term treated groups compared to the control groups, but in the group treated with glucocorticoid for 90 days, a reduction in the bending strength of the rat cortical bone was found. Furthermore, this reduction in strength was found after correction for the reduced thickness of cortical bone in the glucocorticoid-treated rats. The results could not be explained solely by the fact that glucocorticoid-treated rats had smaller bones. No alterations were found in bone density or bone ash weight relative to dry weight. The data indicate that the reduction in bone strength induced by glucocorticoids is not only caused by a reduction in bone quantity, but also by a decrease in bone quality.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ann Rheum Dis. 1960 Jun;19:135-42 - PubMed
    1. Arthritis Rheum. 1967 Oct;10(5):423-30 - PubMed
    1. J Clin Endocrinol Metab. 1974 Aug;39(2):274-82 - PubMed
    1. Adv Exp Med Biol. 1984;171:111-9 - PubMed
    1. Med Biol Eng Comput. 1984 May;22(3):251-4 - PubMed

Publication types